Globe Life
- Market cap
- 12.56B
- P/E (TTM)i
- 10.87
- P/Bi
- 2.04
- EPSi
- 14.07
- Div yieldi
- 0.73%
- 52W posi
- 57%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Fair Value how this is computed
- Implied fair-value range of 136.01-207.94, from this stock's own trailing 5-year average P/E applied to trailing EPS.
- Current price is -5.0% below the average-multiple fair value of 171.98.
Valuation each multiple against its own 5-year range
Vs. peers Insurance - Life
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Globe Life (GL) | 12.56B | 10.87 | 2.04 | 0.73% |
| Manulife Financial (MFC) | 68.93B | 16.10 | 2.11 | 3.13% |
| MetLife (MET) | 60.87B | 18.35 | 2.22 | 2.40% |
| Aflac Inc (AFL) | 56.52B | 12.16 | 1.86 | 2.11% |
| Prudential Financial (PRU) | 38.76B | 10.19 | 1.23 | 4.89% |
| Prudential (PUK) | 29.39B | 8.28 | 1.48 | 2.26% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 5.9% above Morningstar's fair value estimate.
Fair value
Globe Life Inc earns a 2-star quantitative star rating, illustrating our stance that this share class is a somewhat unattractive choice, and investors should look elsewhere for more fruitful opportunities. The stock currently trades at a 8% premium over our quantitative fair value estimate of $153.75 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.
The firm's balance sheet undermines our estimated valuation. Excessive leverage heightens financial risk, potentially undermining a firm's value. For example, the firm's EBITDA/interest coverage ratio of 11.7 ranks in the bottom 50% compared with peers globally. This gives us pause, as it can be a warning sign of financial distress if conditions don't improve. We believe this is a sign that shares could be expensive.
Alternatively, the firm's valuation metrics are reassuring. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to market value ratio of 1.3, a core component of valuation, lies in the top 40% compared with peers globally. While highly leveraged firms can be risky, they can also be highly rewarding. This company's high enterprise value relative to its market value suggests that wise investments will yield outsize returns for investors. Despite our unfavorable price/fair value ratio, this characteristic is a positive attribute.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.
Economic moat
The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.
By Quantitative Equity Report
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.